| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9268327 | Journal of Clinical Virology | 2005 | 5 Pages |
Abstract
Because IgY are resistant to the gastric barrier, the recently described DNA-designed IgY specific to H. pylori Urease B can be of particular interest for passive immunotherapy of gastrointestinal tract infections. Another interesting application is the recent generation in our laboratory of DNA-designed IgY antibodies specific to HBsAg mutants. These antibodies are currently being used to design new diagnostic assay for detection of HBV mutants that are undetectable by actual tests. Moreover, this approach allowing a quick and inexpensive production of a new generation of antibodies will provide pertinent tools to link the fields of genomics and protcomics.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Lucyna Cova,